Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Ultra-high-frequency ECG in the Localization of Left Ventricular Conduction Disorders and Prediction of Response to Resynchronization Therapy

NCT07057544 is registered in ClinicalTrials.gov with Faculty Hospital Kralovske Vinohrady as lead sponsor.

NCT NCT07057544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07057544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Ultra-high-frequency ECG in the Localization of Left Ventricular Conduction Disorders and Prediction of Response to Resynchronization Therapy
Lead sponsor
Faculty Hospital Kralovske Vinohrady
Phase
Not applicable
Overall status
Recruiting
Start date
May 1, 2024
Completion date
December 31, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biventricular pacing, intraventricular conduction delay, left bundle branch area pacing, left bundle branch block